patentgrepDocs Get an API key

A61K 38/166

Streptokinase

Official title: {Streptokinase}

A61K38/166 (Streptokinase) appears on 100 US grants and 88 published applications in this corpus.

Search patents in A61K

Granted patents: 100
Published applications: 88
Assignees: 77
Inventors: 188
Latest grant: 22 Apr 2025

Filings by year

A61K 38/166: granted patents and published applications per publication year
Year	Granted patents	Published applications
1976	1	0
1977	0	0
1978	0	0
1979	1	0
1980	0	0
1981	0	0
1982	0	0
1983	0	0
1984	0	0
1985	0	0
1986	1	0
1987	0	0
1988	0	0
1989	4	0
1990	8	0
1991	14	0
1992	6	0
1993	7	0
1994	2	0
1995	1	0
1996	3	0
1997	1	0
1998	7	0
1999	4	0
2000	2	0
2001	2	0
2002	2	4
2003	3	4
2004	2	7
2005	0	4
2006	0	7
2007	3	5
2008	0	3
2009	2	4
2010	3	5
2011	0	3
2012	1	2
2013	1	3
2014	1	2
2015	2	2
2016	1	2
2017	0	4
2018	2	2
2019	2	6
2020	7	5
2021	1	3
2022	1	1
2023	0	2
2024	1	5
2025	1	2
2026	0	1

By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.

Recent patents

Tissue modifier and uses therefor22 Apr 2025US 12,280,095 B2Fibrosoft Pte Ltd
Method of treating acute coronary syndrome20 Aug 2024US 12,066,443 B2Alfred Health
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo15 Feb 2022US 11,246,915 B2Applied Molecular Transport Inc.
Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor15 Jun 2021US 11,034,755 B2Ablynx N. V.
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo13 Oct 2020US 10,799,565 B2Applied Molecular Transport Inc.

Most cited

By later US patents